(AFP)
MANILA, Philippines — Five hospitals in the country have so far been granted compassionate special permits (CSP) to use human-grade ivermectin to treat COVID-19 patients, the Food and Drug Administration (FDA) said Tuesday.
FDA Director-General Eric Domingo confirmed in a text message to INQUIRER.net that the number of hospitals given CSP for ivermectin has increased to five.
Only three hospitals had a CSP to use the drug for COVID-19 patients on April 22.
In an interview on ABS-CBN News Channel, Domingo also disclosed that a company has expressed willingness to file for a certificate product registration (CPR) of imported ivermectin before the FDA.
He said representatives of the company, which he did not identify, have met with drug regulators in the country last week.
Prior to this development, local firm Lloyd Laboratories Inc. applied for a CPR of ivermectin for human use before the FDA.